JAZZ PHARMACEUTICALS
Jazz Pharmaceuticals is a specialty pharmaceutical company that identifies develops and commercializes innovative treatments for important, underserved markets in neurology and psychiatry. Jazz Pharmaceuticals focuses on identifying, developing, and commercializing products for neurology and psychiatry primarily in the United States. Its products include Xyrem for the treatment of cataplexy and excessive daytime sleepiness in patients with narcolepsy; Cystadane for the treatment of homocystinuri... a, an inherited metabolic disease; and Antizol to treat ethylene glycol and methanol poisoning. Its late-stage product candidates comprise Luvox CR, an extended-release formulation of fluvoxamine, a selective serotonin reuptake inhibitor, which is used for the treatment of obsessive-compulsive disorder and social anxiety disorder; and JZP-6, a liquid dosage form of sodium oxybate in Xyrem, for the treatment of fibromyalgia syndrome.
JAZZ PHARMACEUTICALS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2003-01-01
Address:
Palo Alto, California, United States
Country:
United States
Website Url:
http://www.jazzpharma.com
Total Employee:
501+
Status:
Active
Contact:
6504962651
Email Addresses:
[email protected]
Total Funding:
1.96 B USD
Technology used in webpage:
LetsEncrypt Apache Wordpress Plugins Global Site Tag IPv6 JQuery CDN Hubspot Wordfence TablePress Wistia
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
CANbridge Pharmaceuticals
CANbridge Pharmaceuticals is a bio-pharmaceutical company accelerating development and commercialization of specialty healthcare .
FORMA Therapeutics
FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.
NovaBay Pharmaceuticals
NovaBay Pharmaceuticals is a biopharmaceutical company developing products for the eye care market.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2021-02-03 | GW Pharmaceuticals | GW Pharmaceuticals acquired by Jazz Pharmaceuticals | 7.2 B USD |
2019-08-13 | Cavion | Cavion acquired by Jazz Pharmaceuticals | 321.5 M USD |
2019-07-10 | Redx Pharma | Redx Pharma acquired by Jazz Pharmaceuticals | N/A |
2016-05-31 | Celator Pharmaceuticals | Celator Pharmaceuticals acquired by Jazz Pharmaceuticals | 1.5 B USD |
2016-05-11 | Amolyt Pharma | Amolyt Pharma acquired by Jazz Pharmaceuticals | 20.5 M USD |
2013-12-19 | Gentium | Gentium acquired by Jazz Pharmaceuticals | N/A |
2012-04-26 | EUSA Pharma | EUSA Pharma acquired by Jazz Pharmaceuticals | 650 M USD |
2011-09-19 | Azur Pharma | Azur Pharma acquired by Jazz Pharmaceuticals | N/A |
2005-04-19 | Orphan Medical | Orphan Medical acquired by Jazz Pharmaceuticals | 122.6 M USD |
Investors List
Longitude Capital
Longitude Capital investment in Post-IPO Equity - Jazz Pharmaceuticals
Kingsbridge Capital
Kingsbridge Capital investment in Post-IPO Equity - Jazz Pharmaceuticals
Thoma Cressey Equity Partners
Thoma Cressey Equity Partners investment in Series B - Jazz Pharmaceuticals
Lehman Brothers
Lehman Brothers investment in Series B - Jazz Pharmaceuticals
Adams Street Partners
Adams Street Partners investment in Series B - Jazz Pharmaceuticals
Beecken Petty O'Keefe & Company
Beecken Petty O'Keefe & Company investment in Series B - Jazz Pharmaceuticals
EGS Healthcare Capital Partners
EGS Healthcare Capital Partners investment in Series B - Jazz Pharmaceuticals
Prospect Venture Partners
Prospect Venture Partners investment in Series B - Jazz Pharmaceuticals
Golden Gate Capital
Golden Gate Capital investment in Series B - Jazz Pharmaceuticals
Versant Ventures
Versant Ventures investment in Series B - Jazz Pharmaceuticals
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2021-07-29 | Onera Health | Jazz Pharmaceuticals investment in Series B - Onera Health | 10.5 M EUR |
2019-04-24 | Onera Health | Jazz Pharmaceuticals investment in Series A - Onera Health | 8.16 M EUR |
2019-04-23 | Onera | Jazz Pharmaceuticals investment in Series A - Onera | 9.3 M USD |
2016-05-25 | Arrivo BioVentures LLC | Jazz Pharmaceuticals investment in Series A - Arrivo BioVentures LLC | 49 M USD |
Official Site Inspections
http://www.jazzpharma.com Semrush global rank: 497.81 K Semrush visits lastest month: 100.19 K
- Host name: ec2-44-224-64-152.us-west-2.compute.amazonaws.com
- IP address: 44.224.64.152
- Location: Boardman United States
- Latitude: 45.8491
- Longitude: -119.7143
- Metro Code: 810
- Timezone: America/Los_Angeles
- Postal: 97818